Novartis signs $1bn licensing deal with MorphoSys and Galapagos
Novartis Pharma has signed a worldwide, exclusive agreement to licence atopic dermatitis drug candidate MOR106,...
Novartis Pharma has signed a worldwide, exclusive agreement to licence atopic dermatitis drug candidate MOR106,...